Reports On Pfizer Inc. Drug Studies Misleading, University of California, San Francisco (UCSF) And Bloomberg School of Public Health Researchers Report

Published: Nov 12, 2009

Bookmark and Share

AP -- Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internal company documents showed.

Back to news